AbbVie Ltd Investigator-Initiated Studies 2025

Abbvie is committed to supporting investigator-initiated research that promotes the advancement of medical and scientific knowledge involving AbbVie’s products and therapeutic areas of interest.

Following the review of the initial submission, you may be asked to submit a full protocol and final study budget for further evaluation. Submission of proposals does not guarantee approval. The committee evaluates proposals according to scientific merit, alignment with our areas of research interest and available funding. Financial and/or product support is contingent upon full execution of the research agreement by both parties.

Therapeutic areas of interest:

• Aesthetics
• Eye care
• Immunology
• Neuroscience
• Oncology

Open until the end of 2025